Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>The success that ticagrelor has achieved in acute coronary syndromes prompted the question of whether ticagrelor might provide greater reduction in cardiovascular events than clopidogrel.</p>

Comparing Treatments for Peripheral Artery Disease Patients